Company intelligence / Profile preview

Carl Roth

Karlsruhe, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Carl Roth is not a drug discovery or development company and does not have its own clinical-stage therapeutics programs. Instead, it supplies research tools, chemicals, laboratory products, and life science consumables used in health, biomedical, and biotechnological research. The company has recently expanded into distributing advanced 3D bioprinting materials for tissue engineering and regenerative medicine applications[1][7].

Industry: Chemicals & Materials

Partnerships

BIO INX (distribution of 3D bioprinting bioinks)[1]

Beyond the preview

Go deeper on Carl Roth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carl Roth.

Explore the full profile